Phase 4 Depression and Anxiety Trial, Recruiting NCT06874452 Sponsor: National Taiwan University Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT06874452
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old.
  • People who are already enrolled in a related study called "Anxiety and surgery satisfaction for cataract patient with different state anxiety" (Ethics Case No.: 202302067MINB).
  • People who are planning to have cataract surgery (using a technique called phacoemulsification with lens implant) on their second eye, using eye-drop anaesthesia, at the Ophthalmology Department.
  • People who have not had any bad reactions or side effects from the medication XANAX (alprazolam).

Who may not be able to join:

  • People for whom surgery of any kind is considered unsafe or not recommended.
  • People for whom any relevant medication is considered unsafe or not recommended.
  • People who are unable to answer questionnaires clearly and completely, or who report no anxiety before the operation, or who score below 21 on a standard anxiety assessment tool called the STAI-S or STAI-T (confirm with trial site).
  • People who regularly use anti-anxiety medicines, sleeping pills, or pain relief medications before the procedure.
  • People who are pregnant or breastfeeding at the time before surgery.
  • People who have serious eye conditions such as severe corneal disease, a very advanced cataract, very small pupils, or a dislocated lens that would make standard surgery more difficult.
  • People who are unable to fully cooperate during surgery performed under eye-drop anaesthesia.
  • People who are pregnant or possibly pregnant — the research team will verbally ask women under the age of 55 about this.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Chiun Ho Hou, Ph.D, National Taiwan University Hospital

Phone: +88623123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
25 March 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Anesthesia Satisfaction Assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov